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Hypoalbuminemia causes high blood viscosity by increasing red
cell lysophosphatidylcholine
Jw A. JoLEs, NEL WILLEKES-KOOLSCHUN, and HEIN A. KooNs
Department of Nephrology, University Hospital Utrecht, the Netherlands
Hypoalbuminemia causes high blood viscosity by increasing red cell
lysophosphatidyicholine. Albumin deficiency is accompanied by a reduc-
tion in red cell deformability and blood hyperviscosity. Albumin deficiency
increases plasma fibrinogen and triglyceride levels and may alter red cell
membrane lipid composition. These options, which could all contribute to
reduced red cell deformability (RCD) and hyperviscosity, were studied in
the Nagase analbuminemic rat (NAR), a mutant Sprague Dawley rat
(CON), characterized by normal total protein levels, with an absolute
deficiency of albumin, but elevated levels of non-albumin proteins and
hyperlipidemia. Plasma protein-binding of the polar phopholipid lyso-
phosphatidyicholine (LPC) was markedly decreased. LPC comprised only
26 1% of total plasma phospholipids as compared to 42 2% in CON.
NAR red cells in CON plasma had a viscosity that was similar to CON red
cells in CON plasma. Conversely, CON red cells in NAR plasma show an
increased viscosity as compared to CON red cells in CON plasma. The
maximum deformation index of both NAR and CON red cells was
markedly decreased in NAR plasma as compared to either NAR or CON
cells in CON plasma (0.04 0.03 and 0.02 0.02 vs. 0.22 0.06 and
0.15 0.04, respectively; P < 0.05). Thus, plasma composition causes
hyperviscosity and reduced RCD in NAR. Fibrinogen is not responsible
since red cells in serum and red cells in plasma had a similar viscosity and
differences in viscosity and RCD between NAR and CON were main-
tained. Plasma triglycerides are also not responsible since the viscosity of
red cells in serum with a 50% reduction in triglycerides was not reduced.
LPC levels in red cells were increased in NAR (8.7 0.2 vs. 5.5 0.3%
of total phospholipids; P < 0.01). Adding albumin to NAR blood
dose-dependently decreased whole blood viscosity, despite marked in-
creases in plasma viscosity, and increased RCD of NAR cells (from 0.04
0.03 to 0.21 0.01; P < 0.05). There was also some effect on CON RCD
of similar albumin addition to CON blood (from 0.15 0.04 to 0.29
0.03; P < 0.05). Adding albumin to NAR blood reduced red cell LPC
content and increased plasma LPC content in a dose-dependent fashion,
whereas there were only slight effects of adding albumin to CON blood.
There was a reciprocal relation between red cell LPC and the other polar
phospholipids in the red cell membrane, probably indicating exchange.
The maximum deformability index of either NAR or CON cells was not
affected much by adding LPC to CON plasma (NAR, from 0.22 0.06 to
0.18 0.10; CON, from 0.15 0.04 to 0.12 0.05; NS), whereas adding
LPC to NAR plasma caused the red cells to become rigid. Adding LPC to
CON red cells in NAR plasma caused a much stronger increase in relative
LPC content (from 6.6 0.7 to 10.9 0.9%; P < 0.05) than adding LPC
to CON red cells in CON plasma (from 5.6 0.4 to 6.4 0.8%; NS).
Thus, in the absence of albumin, LPC in red blood cells is increased. As a
consequence of the latter, RCD is decreased and whole blood viscosity
increased. Alterations in red cell phospholipids are far more important
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than increases in plasma fibrinogen or triglycerides in determining hyper-
viscosity of blood and reduced RCD in NAR.
Elevated whole blood viscosity has been reported in several
conditions associated with an increased risk of atherosclerosis,
indicating that rheological properties may be important determi-
nants of cardiovascular disease [1—6]. Whole blood viscosity is a
complex phenomenon and is determined by plasma viscosity and
several red cell related variables of which the hematocrit is the
most important. At high shear rates, reduced red cell deformabil-
ity (RCD) causes an increase of whole blood viscosity. RCD
depends upon characteristics of the red cell membrane and upon
the environment, that is, plasma composition [7]. Decreased RCD
is found in clinical syndromes such as combined hyperlipoprotein-
emia [8], diabetes mellitus [9, 10], and disease states where
macroglobulin or fibrinogen are increased [7].
Whether changes in plasma composition affect RCD via an
increase in plasma viscosity or via a direct effect on membrane
composition is, however, unclear. In this respect albumin defi-
ciency is interesting, since in this condition changes in plasma
protein and lipid composition coincide. Indeed, in the nephrotic
syndrome RCD is consistently reduced [11]. Since albumin binds
certain lipid fractions such as lysophosphatidyicholine (LPC) and
fatty acids [12], it may very well be that albumin deficiency causes
a reduction in RCD by altering membrane lipid composition.
Other alterations in plasma composition in this condition, notably
high fibrinogen and hypertriglyceridemia, have been associated
with increased plasma viscosity [13], and whole blood viscosity
[14]. However, no direct investigation of the effect on RCD of
either of these factors or of hypoalbuminemia as such has been
reported.
Plasma protein-binding of negatively-charged lipid products
such as non-esterified fatty acids and LPC is markedly decreased
in the Nagase analbuminemic rat (NAR) [15] and in analbumin-
ernie patients [16]. LPC is normally bound to albumin [17]. In
NAR, a mutant Sprague-Dawley rat (CON), which is character-
ized by normal levels of total protein, an absolute deficiency of
albumin, elevated levels of high and low molecular weight pro-
teins [18—20] and hyperlipidemia [21, 22], LPC was primarily
bound to lipoproteins, and, although LPC production was in-
creased by increased cholesterol esterification [23], total LPC in
plasma was decreased, suggesting accumulation in a different, as
yet unidentified, pool. Hypothetically, one such pooi could be the
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red cell membrane. There is a rapid turnover of both phosphati-
dylcholine (PC) and LPC between the plasma and the red cell
membrane [24]. Levels of LPC as low as 0.1 m are known to
decrease red cell elasticity (measured as filterability) [25], whereas
changes in morphology can be observed at 4 m, and hemolysis
occurs at 40 m [26].
If albumin deficiency affects RCD by an effect on lipid compo-
sition of the red cell membrane, then correction of the abnormal-
ities in plasma proteins and lipoproteins that occur secondary to
hypoalbuminemia, without restoration of normalbuminemia,
should not be able to normalize RCD. On the other hand, the
addition of albumin to normalize plasma albumin concentration
should correct RCD and decrease whole blood viscosity, while
increasing plasma viscosity. We tested this novel hypothesis in the
NAR.
Viscosity in relation to shear rate was studied in a Couette flow
and RCD was studied with a laser diffraction technique. The effect
of various plasma components was studied by using a suspending
medium consisting of plasma, serum, delipidated serum, plasma
with added albumin or plasma with added LPC. Whole blood
viscosity was measured at constant hematocrit and for RCD the
suspending medium was used as a solvent for carboxymethylcel-
lulose. Viscosity and RCD measurements were made in various
combinations of NAR and CON cells and plasma. Furthermore,
the effects of plasma albumin concentration on red cell membrane
and plasma phospholipid composition were studied. We made the
novel finding that in albumin deficiency red cell membrane LPC
content is increased and associated with decreased red cell
deformability, and that albumin supplementation decreases whole
blood viscosity while increasing plasma viscosity.
METHODS
Animals
Adult female Nagase analbuminemic rats (NAR; CLEA, To-
kyo, Japan) and Sprague-Dawley rats (CON; HSD/OLAC; Har-
lan-CPB, Zeist, The Netherlands) were maintained under con-
ventional conditions. Rats were exsanguinated under barbiturate
anesthesia. The protocol was approved by the Utrecht University
Board for study in experimental animals.
Blood was sampled from the abdominal aorta in dry K2-EDTA
for all viscosity and RCD measurements. Fibrinogen was deter-
mined in blood collected in 0.1 ml 10% (wt/vol) Na—citrate. Cells
and plasma were immediately separated by centrifugation at 4°C
unless otherwise specified. Measurements were performed in
fresh cells and plasma.
Analytical methods
Plasma protein spectrum was assessed by cellulose acetate
electrophoresis. Plasma protein concentration was determined
colorimetrically (Bio—Rad Lab., Munich, Germany). Plasma albu-
min and fibrinogen levels were measured by immunoturbidometry
using rabbit-anti-rat albumin and goat-anti-rat fibrinogen (Nordic,
Tilburg, The Netherlands). Rat albumin (Fraction V) and fibrin-
ogen (Sigma; St. Louis, MO, USA) were used as references. Three
different dilutions of the standard were run on each plate. all
samples were run in duplicate. Plasma lipids were determined
enzymatically (total plasma cholesterol and triglycerides, Boehr-
inger, Mannheim, Germany; plasma phospholipids, Wako Chem-
icals, Neuss, Germany). Plasma and red cell membrane phospho-
lipid composition was measured by thin-layer chromatography.
Phospholipids were extracted in a stepwise fashion, first with a
mixture of methanol (2.53 X fraction volume) and chloroform
(1.27 x fraction volume), then with chloroform and water (both
1.27 x fraction volume). The chloroform fraction was then
evaporated, and the residue dissolved in 2 ml chloroform:metha-
nol (2:1, vol:vol). Phosphorus content was determined with a
modified Bartlett procedure [27]. Phospholipid species were
separated by thin-layer chromatography. An aliquot containing
300 nmol phosphorus was evaporated, and the residue dissolved
in 100 ml chloroform:methanol (2:1, vol:vol) and spotted onto the
plate. Separation of phospholipid species was achieved using a
solvent composed of chloroform:methanol:acetic acid:water (100:
50:16:4, vol:vol). Phospholipids were visualised with iodine,
scraped from the plate, and phosphorus content of the various
species (lysophosphatidylcholine, LPC; sphingomyelin, SM; phos-
phatidylcholine, PC; phosphatidylinositol, P1; phosphatidylserine,
PS; phosphatidylethanolamine, PE) in each sample was deter-
mined with the modified Bartlett procedure [27].
Viscosity measurements
Plasma and whole blood viscosity were measured at 39°C on a
Contraves Low shear 30 viscosimeter (Contraves A.G., Zurich,
Switzerland) at six shear rates ranging from 6 to 50 seconds'.
Plasma is a Newtonian fluid for which the viscosity is independent
of shear rate. Thus, plasma viscosity was calculated as the mean
value of these six measurements. Hematocrits of all blood samples
were determined by centrifugation of 40 ml of the sample in a
capillary tube in a microhematocrit centrifuge for five minutes.
Blood was reconstituted to a hematocrit of 42 1%. Whole blood
viscosity was log-log transformed and compared by analysis of
covariance.
Determination of red cell deformability
Red cell deformability (RCD) was measured by a laser diffrac-
tometer, essentially as described [28—30]. A system constructed
around the Contraves Low Shear 30 viscosimeter was used, in
which shear-rates could be varied between 0.56 and 410.5 sec-
onds1. A 0.75 MW He-Ne laser beam (model 155; Spectra
Physics, Mt. View, CA, USA) was transmitted through a sample
holder consisting of a perspex cup with an inner diameter of 41
mm which turned around a perspex cylinder with an outer
diameter of 40 mm, The space between the inner and outer
cylinder required a sample volume of 2.25 ml. Just before the
measuring procedure, a sample of 10 ml whole blood or red cell
suspension, prewarmed to 39°C, was added to 2.25 ml carboxy-
methylcellulose (CMC, medium viscosity grade PH; EUR Phar-
bita, Zaandam, The Netherlands) either in plasma or in phos-
phate-buffered saline (PBS, 290 mOsm/liter, pH 7.4) at a final
concentration of 1.6% CMC. The osmolality of the CMC/PBS
solution was 345 7 mOsm/kg. The osmolality of the CMC/
plasma solutions was 340 16 mOsm/kg for NAR plasma and
345 20 rnOsm/kg for CON plasma. Although these values were
hypertonic, they were not different between PBS and plasma of
either NAR or CON. During measurements, the temperature was
kept constant at 39°C. The viscosity of the CMC suspension was
between 60 and 70 rnpa second, resulting in a maximum shear
stress of about 25 N/rn2. The outer cylinder was rotated at
decreasing rotational speeds around the fixed inner cylinder,
thereby exposing the red cells to varying shear stress. The applied
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Table 1. Plasma protein composition of analbuminemic rats (NAR) in
comparison to control rats (CON)
NAR CON
64.0 2.0
42.30 2.74
70.7 1.3
3.7 0.6k
4.3 1.0
3.7 0.4
17.4 i.oa
Total plasma protein and plasma albumin in g/liter; fractional values of
a-i, a-2,3, 13 and y-globulins. The results are expressed as mean
standard deviation.
P < 0.01 versus NAR
shear stress caused the red cells to transform from the biconcave
shape to the ellipsoid shape, aligned along the streamlines of flow.
Laser light sent through the sheared suspension was scattered by
the red cells. The resulting diffraction pattern was projected on
frosted glass, detected by a video camera and analyzed by a
computer assisted image analyzer (40 to 10 Image Analyzer;
Analytical Measuring Systems Ltd. Shirehill, UK). Deformation
was expressed as the deformation index of the diffraction pattern
of the cells as function of the shear stress 1301. The axis ratio of
this pattern corresponds to the mean axis ratio of the deformed
cells, and is therefore a valid parameter to quantify the extent of
deformation of the red cells [31].
Delipidation of serum
Blood from non-fasted rats was collected in plain glass tubes for
serum. Serum was delipidated by ultracentrifugation in an Airfuge
at 130,000 Xg for 30 minutes.
Effects of albumin and lysophosphatidyicholine (LPC)
In these experiments fatty-acid free bovine serum albumin
(Sigma) was added to NAR and CON blood in concentrations
ranging from 3 to 60 glliter blood. The albumin was added to the
blood 60 minutes before the viscosity and deformability measure-
ments. During this period the blood was kept at room tempera-
ture. LPC was added to NAR and CON plasma at a concentration
of 24 mg/mI, which was equivalent to the difference in erythrocyte
LPC content per ml of blood in NAR and CON. Reconstituted
blood was used after 60 minutes at room temperature to assess the
effects of added LPC on red cell phospholipids.
Statistical analysis
The results were expressed as mean SD for (N) separate
experiments. Student's f-test was used to determine the signifi-
cance of differences between means. Differences between whole
blood viscosity and reconstituted blood of NAR and CON in
autologous and heterologous plasma were determined by analysis
of covariance after log-log transformation of the data.
RESULTS
Plasma proteins
Total plasma protein concentrations were comparable in NAR
and CON rats. Plasma albumin was almost completely absent in
NAR. The protein spectrum was markedly deranged in NAR
40
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Fig. 1. Whole blood viscosity in analbuminemic (•) and Sprague-Dawley(0) rats. Note that shear rate is presented on a log scale.
(Table 1). The fractional values of the other proteins were higher
in NAR than in CON. The amount of the a-i fraction was
particularly high, more than 12 times that of CON rats.
Baseline viscosity measurements
Hematocrits were not different between the strains (NAR,
0.41 0.02; CON, 0.44 0.01). Whole blood viscosity and plasma
viscosity in NAR (N = 7) and CON (N = 7) were measured in a
Couette type viscosimeter at shear rates ranging from 6.0 to 50
seconds1 (Fig. 1). Whole blood viscosity in NAR was increased
at all shear rates tested (P < 0.001); plasma viscosity was
independent of the applied shear rate and the results at different
shear rates were averaged. Mean plasma viscosity in NAR was
significantly elevated as compared to CON (1.9 0.2 vs. 1.5 0.1
mPa - second; P < 0.01, respectively). Relative viscosity (whole
blood viscosity/plasma viscosity), an index for the intrinsic contri-
bution of the red blood cell to whole blood viscosity, was increased
in NAR (from 21.3 2.6 vs. 11.9 1.6 mPa - second in CON at
a shear rate of 6 seconds1 to 6.9 0.8 vs. 5.6 0.7 mPa second
at a shear rate of 51 seconds1), suggesting a reduced RCD in
NAR.
Autologous and heterologous viscosity and RCD measurements
Viscosity measurements of NAR and CON red cells, reconsti-
tuted to a hematocrit of 0.42 in pooled autologous or heterolo-
gous plasma, were performed to study the effect of variations in
plasma composition on whole blood viscosity (Fig. 2A). The
highest viscosity was found with NAR cells resuspended in NAR
plasma (P < 0.001). Intermediate values were observed for CON
cells resuspended in NAR plasma; the lowest and not significantly
different levels were observed for NAR and CON cells in CON
plasma.
RCD of NAR and CON were determined by laser diffractom-
etry. NAR or CON red blood cells (10 ml) were added to a 1.6%
carboxymethylcellulose (CMC) solution in PBS in order to obtain
high shear stresses. NAR red cells were significantly less deform-
able in buffer (P < 0.01; Table 2 and Fig. 3). To study the effect
of plasma components on RCD, 1.6% CMC was dissolved in
pooled NAR or CON plasma.
50
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Total protein g/liter
Albumin g/liter
Pre-albumin + albumin %
a-i %
a-2,3 %
13%
7
67.9 6.4
0.14 0.08
4.5 0.5
45.2 1.7
9.3 1.2
5.4 0.7
35.7 2.1
0
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Fig. 2. (A) Reconstituted blood viscosity with cells from analbuminemic
(NAR; •) and Sprague-Dawley (CON; 0) rats. Homologous and heter-
ologous plasma was used from NAR (solid lines) and CON (dashed lines)
rats. (B) Reconstituted red cell deformation with cells from analbumin-
ernie (NAR; •) and Sprague-Dawley (CON; 0) rats. Homologous and
heterologous plasma from NAR (solid lines) and CON (dashed lines) rats
was used as a solvent for carboxymethylcellulose (1.6%).
RCD measurements of NAR and CON red blood cells in either
autologous or heterologous plasma were performed. The maxi-
mum deformation index was much higher in CON plasma than in
NAR plasma, irrespective of the cell type (Fig. 2B and Table 2),
even though the maximum deformation index of red blood cells of
both rat strains was lower in CON plasma than in buffer (Table 2).
Unexpectedly, NAR red cells suspended in CON plasma were
significantly more deformable than CON cells in CON plasma.
Phospholipid composition of plasma and red cell membranes
Phospholipid concentrations were increased in NAR plasma.
The relative contribution of lysophosphatidylcholine (LPC) to
total phospholipid species was reduced from 42.3 1.0% in CON
plasma to 26,5 0.5% in NAR plasma (P < 0.001; Table 3).
Relative contributions of PC and PE were increased, whereas SM
was slightly reduced and P1 + PS were not different. Phospholipid
NAR red cells
(N)
CON red cells
(N)
Saline 0.247 0.043 (14) 0.318 0.37 (8)
NAR plasma 0.038 0.027 (6) 0.017 0.017 (8)
NAR serum
CON plasma
0.039 0.045 (4)
0.217 0.056" (8)
N.D.
0.15 1 0.036a (8)
CON serum N.D. 0.221 0.025C (4)
NAR plasma + LPC
CON plasma + LPC
0.00 (2)
0.175 0.097" (4)
0.00 (2)
0.120 0.048" (5)
concentrations were normal in NAR red cells. The relative
contribution of lysophosphatidyicholine (LPC) to total phospho-
lipid species was increased from 5.5 0.1% in CON cells to 8.7
0.4% in NAR cells (P < 0.001; Table 3), and there was also an
absolute increase in red cell LPC concentration (CON: 0.033
0.006 and NAR 0.047 0.006 mmol/liter blood; P < 0.05).
Relative contributions of SM, PC and P1 + PS remained un-
changed, whereas PE was decreased. Total blood LPC was only
slightly different (CON, 0.435 0.023 mmol/liter and NAR,
0.532 0.079; P = 0.058). The hematocrit was also similar (NAR,
38.5 0.9 and CON, 37.90.5%).
Viscosity and RCD in plasma and serum and in serum after
delipidation
The possible effect of plasma fibrinogen and triglycerides on
viscosity and RCD was investigated by comparing plasma, serum
and delipidated serum. Plasma fibrinogen and serum lipids before
and after delipidation of the serum in NAR and CON are listed in
Table 4. Fibrinogen was nearly twice as high in NAR as in CON.
The viscosity of NAR serum was lower than of NAR plasma, but
this difference was not found for CON serum and CON plasma.
Nevertheless, NAR serum was still hyperviscous as compared to
A Table 2. Maximum deformation index of red blood cells in saline(PBS) and in homologous and heterologous plasma
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The effect of the addition of lysophosphatidylcholine (LPC; 24 g/ml
blood) were also measured. Data presented as mean standard deviation.
P < 0.05 vs. NAR cells; P < 0.01 vs. NAR cells
"P < 0.05 vs. NAR plasma
P < 0.05 vs. CON plasma
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100 500 Fig. 3. Red cell deformation with cells from analbuminemic (•) and
Sprague.Dawley (0) rats suspended in carboxymethylcellulose dissolved
in PBS (1.6%).
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Table 3. Distribution of phospholipids in plasma and red cell membranes
NAR_plasma CON_plasma NAR red cells CON red cells
N 4 4 4 4
Total phospholipids rnnwl/liter 4.00 0.62 1.54 0.190 4.19 0.49 4.71 0.18
Lysophosphatidylcholine % 26.45 1.03 42.25 2.00' 8.70 0.23 5.50 0.29'
Sphingomyelin % 10.98 1.58 14.80 0.910 10.80 1.39 9.35 0.41
Phosphatidylcholine % 56.10 1.65 38.13 2.07' 49.23 2.96 47.68 0.82
Phosphatidylinositol + phosphatidylserine % 4.03 0.79 3.70 1.15 11.10 0.26 11.13 0.29
Phosphatidylethanolamine % 2.50 0.14 1.15 0.17k' 20.23 2.19 26.35 1.05
Data are presented as mean standard deviation.
'P < 0.01 vs. NAR
N
Biochemistry
Plasma fibrinogen glliter
Serum
Cholesterol mmol/liter
Triglycerides mmol/liter
Delipidated serum
Cholesterol mrnol/liter
Triglycerides mmol/liter
Viscosity mPa second
Plasma
Serum
Delipidated serum
Data are presented as mean
°P < 0.01 vs. NAR
h p < 0.05 vs. serum
P < 0.05 vs. plasma
6.2 0.40
25
2.5 0.3"
0.6±0.20 20
2.7±0.40
0.6 0.2k' g(J)
1.047 0.031' >
1.041 0.0340
1.023 0.0150
CON serum. Viscosity of red cells resuspended in autologous
plasma or serum was not different (Fig. 4A), and the NAR
samples remained hyperviscous as compared to CON. Deform-
ability of NAR and CON red blood cells was determined in
autologous plasma and serum (Fig. 4B). Although RCD of
autologous CON cells was higher in serum than in plasma, the
increase was absent in NAR (Table 2), despite the fact that
plasma fibrinogen levels were much higher in NAR. Serum
cholesterol and triglyceride concentrations were significantly ele-
vated in NAR. After delipidation, serum triglycerides were re-
duced by 50% in NAR, with little effect in CON. A 50% reduction
in triglyceride levels had no effect on viscosity in either NAR or
CON serum, and the difference in serum viscosity between the
strains was maintained, Viscosity of red cells resuspended in
autologous serum or delipidated serum was not different (Fig.
4A), and the NAR samples remained hyperviscous as compared
to CON.
Effects of albumin on viscosity and RCD and red cell
membrane phospholipids
In the baseline situation, characteristic differences in NAR and
CON plasma were present, that is, similar total protein concen-
trations and marked hyperlipidemia in the NAR (Table 5).
Adding fatty-acid free BSA to NAR and CON blood caused a
dose-dependent increase in plasma viscosity (Table 5). Differ-
ences in plasma viscosity between NAR and CON plasma were
maintained at all concentrations. In striking contrast, adding
fatty-acid free BSA to NAR and CON blood caused a dose-
Table 4. Effects of fibrinogen and triglycerides on plasma viscosity
NAR CON
6 6
A
35
30
11.8 1.5
7.4 0.5
5.1 1.9
7.3 0.2
2.4 0,7h
1.281 0.029
1.204 0.0300
1.194 0.0130
standard deviation, 0
5
10
B
Shear rate/seconds
1005
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0.10
E
0.00
—0.10
0.01 0.1 1 10 100 500
Shear stress, N/rn2
Fig. 4. (A) Reconstituted blood viscosity with cells from anaJbuminemic
(•) and Sprague-Dawley (0) rats. Homologous plasma (solid lines),
serum (dashed lines) and delipidated serum (stippled lines) were used.
Characteristics of plasma, serum and delipidated serum are listed in Table
2. (B) Reconstituted red cell deformation with cells from analbuminemic
(•) and Sprague-Dawley (0) rats. Homologous plasma (solid lines) and
serum (dashed lines) were used as a solvent for carboxymethylcellulose
(1.6%).
dependent decrease in viscosity of both NAR and CON blood
(Fig. 5A). Differences in whole blood viscosity between NAR and
CON plasma were also maintained at all concentrations. Thus,
adding albumin to blood causes a marked decrease in relative
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Table 5. Effects of adding increasing amounts of fatty acid-free BSA on
plasma viscosity
MAR (N = 6) CON (N = 6)
Protein gIlder 54.1 1.46 56.4 2.20
Cholesterol mmollliier 5.44 0.62 2.50 0.28a
Triglycerides ,nmol/liter 3.53 0.93 0.58 0.18
Phospholipids mmol/liter 4.09 0.47 1.96 0.20a
NAR (N = 6) CON (N = 6)
Plasma Plasma
BSA glider protein Viscosity protein Viscosity
blood glliter mPa second glider mPa second
0 52 7 1.313 0.014 55 1.086 0.014'
3 63 1.336 0.016 66 1.108 0.013'
10 65 6 1.421 0.015 71 12 1.161 0.022k'
30 98 9 1.705 0.018 106 2 1.365 0.022'
60 145 7 2.405 0.025 142 3 1.728 0.026
viscosity, indicating that albumin specifically reduces relative
viscosity, and hence probably increases RCD. This was confirmed
in NAR at concentrations of BSA of 30 and 60 g/liter blood (Table
6 and Fig. 5B).
The addition of albumin to NAR blood reduced red cell LPC
content and increased plasma LPC content in a dose-dependent
manner, whereas there was not much effect of adding albumin to
CON blood (Fig. 6). Moreover there was an inverse relation
between the relative content of LPC and of the total of the polar
phospholipid species (P1 + PS + PE) (Fig. 7A), which was not
observed between LPC and the neutral phospholipid species (SM
+ PC), where in fact there appeared to be a weak positive
correlation between LPC and the neutral phospholipids (Fig. 7B).
Effects of LPC on RCD and red cell membrane phospholipids
Adding 24 mg/mI LPC to CON plasma only slightly reduced
RCD of NAR and CON cells, but in NAR plasma both NAR and
CON cells became completely indeformable (Table 2). Addition
of the same concentration of LPC to CON plasma in which CON
cells were reconstituted to a hematocrit of 42% caused only a
small increase in red cell LPC content and a similar small decrease
in content of polar phospholipids, while CON cells reconstituted
in NAR plasma to which this same amount of LPC was added
showed a much larger increase in LPC content and quantitatively
similar fall in polar phospholipid content (Fig. 7A). Non-polar
phospholipids in the red cells tended to increase slightly with
increasing LPC (Fig. 7B).
DISCUSSION
Anaihuminemia appears to he a hyperviscous state. In analbu-
minemic rats, both whole blood viscosity and plasma viscosity
were increased at all shear rates tested. The high whole blood
viscosity in NAR could not be accounted for merely by differences
in hematocrit or plasma viscosity. Relative viscosity (whole blood
viscosity/plasma viscosity), that is considered an index for the
intrinsic contribution of the red blood cell to whole blood
viscosity, was also increased. Indeed, ektacytometry revealed a
decreased red cell deformability (RCD) of both NAR and CON
red cells in NAR plasma. These abnormalities in whole blood
viscosity could not he ascribed to the high fibrinogen or triglycer-
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Fig. 5. (A) Whole blood viscosity in analbuminemic (•) and Sprague-
Dawley (0) rats with albumin added at a concentration of 0 (stippled
lines), 10 (dashed lines) and 60 (solid lines) g/liter blood. (B) Red cell
deformation in anaihuminemic (•) and Sprague-Dawley (0) rats with
cells suspended in carhoxymethylcellulose dissolved in PBS (1.6%) with
albumin added at a concentration of 0 (stippled lines), tO (dashed lines)
and 60 (solid lines) glliter blood.
ide levels, but appeared to be the direct result of lack of
albumin-binding of lysophosphalidylcholine (LPC) and increased
red cell LPC content. This leads to the paradoxical and novel
observation that addition of albumin increases plasma viscosity
but decreases whole blood viscosity in albumin deficiency.
In reconstitution experiments, the highest viscosity was ob-
served with NAR cells resuspended in NAR plasma while CON
cells resuspended in NAR plasma showed intermediate viscosity
values and the lowest viscosity was observed for NAR and CON
cells resuspended in CON plasma. From these observations, a
direct effect of plasma components on red blood cells is suggested,
contributing to the increased whole blood viscosity in NAR. The
higher viscosity of NAR cells in MAR plasma as compared to
CON cells in MAR plasma may be related to incubation condi-
tions.
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Table 6. Maximum deformation index of red blood cells in homologous
and heterologous plasma
NAR red cells (N) CON red cells (N)
NAR plasma 0.038 0.027 (6) 0.017 0.017 (8)
CON plasma 0.217 0.056' (8) 0.151 0.036" (8)
NAR plasma + BSA 0.030 0.019 (4) ND.
lOg/liter blood
NAR plasma + BSA 0.099 0.017" (3) N.D.
30 glliter blood
NAR plasma + BSA 0.214 0.013" (2) N.D.
60 gluier blood
CON plasma + BSA N.D. 0.272 0.026c (2)
lOg/liter blood
CON plasma + BSA N.D. 0.301 0.025w (2)
30 g/liter blood
CON plasma + BSA N.D. 0.292 0.300" (3)
60 gluier blood
The effect of the addition of BSA to blood was also measured. Data are
presented as mean standard deviation.
P < 0.05 vs. NAR cells; P < 0.01 vs. NAR cells
P < 0.05 vs. NAR plasma
P < 0.05 vs. without BSA
60
T
111E1IIIIIIII
-t,
.
:J
0 10 30 60
Bovine albumin, g/liter blood
Fig. 6. Lysophosphatidylcholine levels in red blood cells (circles) and
plasma (squares) in analbuminemic (closed symbols; solid lines) and
Sprague-Dawley (open symbols; dashed lines) rats at various concentra-
tions of fatty-acid free BSA listed in Table 5
The effect of plasma on RCD was studied using a laser
diffraction technique with carboxymethylcellulose dissolved in
PBS or plasma in order to obtain a high shear stress. RCD was
markedly decreased in NAR plasma, irrespective of the cell type.
These observations also suggest that in NAR one or more plasma
components are directly reducing RCD and that this is an
important factor contributing to the increased whole blood vis-
cosity. Once the NAR erythrocyte was taken out of its natural
milieu and suspended in buffer it still showed some reduction in
deformability as compared to CON erythrocytes in buffer. This
may be due to a residual effect of the previous milieu, that is not
corrected in buffer alone. However, when studied in CON plasma
NAR cells were consistently more deformable than CON cells in
autologous plasma. This could he due to some permanent rear-
rangement of the red cell membrane because of high LPC, which
tends to make the structure more flexible when this increased
LPC is corrected. Irrespective of the mechanism underlying the
40
0 5 10 15 20
LPC, %
Fig. 7. (A) Lysophosphatidylcholine (LPC) levels in analbuminemic
(NAR; closed symbols) and Sprague-Dawley (CON; open symbols) red
blood cells in relation to other polar phospholipids (PI+PS+PE) in NAR
plasma (0, •), CON plasma (A), NAR plasma + BSA (•) or con plasma
+ LPC (0'). (B) Lysophosphatidylcholine (LPC) levels in analbuminemic
(NAR; closed symbols) and Sprague-Dawley (CON; open symbols) red
blood cells in relation to non-polar phospholipids (PC+SM) in NAR
plasma (0, S), CON plasma (A), NAR plasma + BSA (U) or con plasma
+ LPC (Ky).
enhanced deformability of NAR erythrocytes in normoalbumin-
ernie plasma, this observation underscores that reduced RCD in
NAR erythrocytes is due to an interaction with extrinsic factors
and not due to intrinsic factors.
The NAR is characterized by marked hypercholesterolemia and
hypertriglyceridemia [21, 22]. No relation was found between
hypercholesterolemia on whole blood viscosity [1, 32] and there is
controversy on the effects on RCD [1, 33, 34]. Hypertriglyceride-
mia, in contrast to hypercholesterolemia, is known to increase
plasma viscosity [35] and is correlated with high whole blood
viscosity [32] and red blood cell rigidity [32]. However, after a 50%
reduction in plasma triglycerides, only a small decrease in plasma
viscosity was observed in NAR, whereas whole blood viscosity was
.
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unaffected. Differences in RCD between NAR and CON per-
sisted, despite the marked reduction in plasma triglycerides,
suggesting that hypertriglyceridemia is not the cause of hypervis-
cosity and decreased RCD in NAR. Furthermore, we have
previously observed that whole blood viscosity was no higher in
female NAR than in male NAR, despite markedly higher triglyc-
eride levels in the females [36], and that ovariectomy in female
NAR markedly decreased plasma triglycerides and plasma viscos-
ity, but did not affect whole blood viscosity [371. Nevertheless,
lipid levels are not as high in this model as sometimes found in the
nephrotic syndrome [13, 14, 23]. Thus, such an additional incre-
ment in hyperlipidemia as well as other changes, such as the
reduction in alpha-I acid glycoprotein that also characterizes the
nephrotic syndrome [38], cannot be addressed in NAR.
In the nephrotic syndrome, the plasma protein spectrum is
abnormal with high molecular weight proteins such as fibrinogen
and a2-macroglobulin increased at the expense of albumin [11,
14]. Similar changes have been observed in NAR [18, 191 and were
confirmed in this study. Elevated plasma [13, 14] and whole blood
viscosities [14] have been reported in patients with the nephrotic
syndrome. These increases were wholy ascribed to changes in
plasma globulins, notably fibrinogen [14]. In normal adults, fibrin-
ogen is also an important determinant of plasma viscosity [32].
However, serum viscosity in NAR, although lower than plasma
viscosity, was still higher than serum viscosity in CON. Moreover,
we found that removal of fibrinogen from NAR and CON plasma
did not eliminate the difference in whole blood viscosity or RCD.
This suggests that either a membrane component or a plasma
component other than triglycerides or fibrinogen plays an impor-
tant role. Fibrinogen is known to stimulate red cell aggregation
[39, 401, but direct effects on RCD have not been reported.
Interestingly, the effects of fibrinogen on RCD were absent in
NAR, despite the fact that plasma fibrinogen levels were very high
in NAR. Apparently, certain changes are induced in red cell
membrane composition in NAR that prevent the absorption of
fibrinogen [41] and thus protect NAR cells from the antidefor-
matory effects of fibrinogen. If this was not the case, RCD would
be even more disturbed in NAR.
Subsequently, we probed the possibility that lack of albumin
was causing an alteration in red cell membrane composition.
Adding albumin to NAR and CON blood caused an increase in
plasma viscosity. In striking contrast, adding albumin to NAR and
CON blood caused a decrease in whole blood viscosity. Such an
effect has never been reported. However, recently a dose-depen-
dent decrease in red cell sedimentation was found after the
addition of albumin [39]. Differences in plasma and whole blood
viscosity between NAR and CON plasma were maintained at all
concentrations. Thus, adding albumin to blood causes a marked
decrease in relative viscosity (whole blood viscosity/plasma viscos-
ity), indicating that albumin specifically reduces relative viscosity,
and hence increases RCD. Interestingly, this effect was not
specific for NAR blood, and it still occurred under hyperalbumin-
ernie conditions with plasma protein levels exceeding 100 g/liter
that were in fact causing marked plasma hyperviscosity. Thus the
positive relation between whole blood viscosity and total plasma
protein [32] must he related to an increase in non-albumin
proteins, because an increase in albumin will have the opposite
effect. Indeed, only the addition of excessive amounts of albumin
completely normalized RCD in NAR. Therefore, a large plasma
protein, other than fibrinogen, may also decrease RCD in NAR.
Previously we had observed that hypoalbuminemia in NAR and
nephrotic rats caused a marked redistribution of LPC from
lipoprotein-deficient plasma to the lipoproteins [23]. However,
despite an increase in cholesterol esterification, total plasma LPC
levels were decreased, suggesting accumulation in a different pool.
Hence we hypothesized that red cell membrane LPC levels were
increased. This hypothesis is directly supported by the observation
that the addition of albumin reduces red cell LPC content and
increased plasma LPC content in a dose-dependent manner and
by the observation that adding a small amount of LPC to NAR
plasma caused a specific reduction in RCD, These findings
indicate that albumin-binding of LPC is critical for maintaining
RCD.
The effect of sublytic concentrations of LPC on the shape of red
blood cells was already described in 1935 by Bergenhem and
Fahreus [reviewed in 42]. LPC induces hemolysis when its con-
centration exceeds 40 m, shape changes are observed at 4 mM
[261, and changes in filterability at concentrations below 0.1 mM
[25]. In the presence of albumin these concentrations are an order
of magnitude higher [43], and shape changes can be restored by
the addition of albumin [44]. In all these experiments LPC was
added to red blood cells in a buffer solution. Our data indicate
that endogenous LPC levels in red cell membranes are kept low in
the circulation by albumin, and that in the absence of albumin the
concentration of LPC in the red cell membranes increases from
0.03 to 0.05 m, RCD falls and whole blood viscosity rises. These
values lie in the same range at which Nakamura et al found
changes in red cell filterability [25]. The amount of LPC in CON
and NAR whole blood is an order of magnitude higher, but in vivo
90% or more is bound mainly to albumin (CON) or lipoproteins
(NAR) [23]. In fact, addition of albumin in vitro increased plasma
LPC content and shifted the LPC from the lipoproteins to the
lipoprotein-deficient plasma (data not shown).
Phospholipids are asymmetrically distributed in the erythrocyte
membrane. The neutral phospholipids, phosphatidylcholine (PC)
and sphingomyelin (SM), are mainly on the outside and the polar
species, PE, phosphatidylserine (PS) and phosphatidylinositol
(P1) are mainly found on the inner side of the membrane bilayer
[451, while LPC, although mainly on the outside [26], can trans-
locate to the inner membrane [46], where it is converted to PC by
phospholipase A2 [45]. The reciprocal relation between the
concentration of LPC and the other polar species in the red cell
membrane possibly indicates that changes in the phospholipid
composition of the inner side the membrane are important
determinants of RCD and that the affinity of LPC to the red cell
is higher than that of the other polar phospholipids.
Hypoalbuminemia probably also affects the incorporation of
LPC into other membranes that are exposed to blood, such as
those of endothelial cells. LPC impairs nitric oxide-mediated
arterial vasodilation [47]. Addition of albumin in vitro causes a
dose-dependent reduction in LPC uptake into cultured endothe-
hal cells, with a steep fall in uptake when the molar ratio of
LPC/alhumin falls from 10 to 2 [48]. LPC, at levels found in
oxidized LDL, niay affect endothelial function by stimulating
protein kinase C at low concentrations (10 mM) [47] and inhibiting
protein kinase C at high concentrations (100 mM) [40]. LPC may
also reduce serotonin-incluced vasodilation by affecting the (1-
protein dependent pathway [50]. The latter experiments were
performed with aortic rings that were exposed to LPC concentra-
tions of 10 M in an albumin-free solution. Multiple observations
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indicate that various actions of LPC on endothelial cells can be
modified by the presence of albumin. Albumin also reduces
platelet and red blood cell accumulation on damaged arterial
surfaces [51].
It is well known that in numerous conditions hypoalbuminemia,
albeit quite mild, increases the risk of morbidity and mortality
[52—54]. Whether this is due to malnutrition, in which case
hypoalbuminemia is merely an epiphenomenon, or due to an
increase in acute-phase proteins because of a chronic low-grade
inflammatory state is under debate [55, 561. The possibility that
hypoalbuminemia, even though quite mild, directly affects RCD
and possibly endothelial function because of a reduction in
LPC-binding capacity, may well be an additional component of
the pattern of risk factors that are associated with hypoalbumin-
emia.
The observations reported in this study indicate that the
correlations between triglycerides or fibrinogen and whole blood
viscosity observed in normal [32] and nephrotic [14] adults may
not indicate causality. Under hypoalbuminemic conditions such as
the nephrotic syndrome, the increased risk for coronary athero-
sclerosis and thrombosis [57] may also be caused in part by
changes in rheological properties [11]. Increased whole blood
viscosity in such hypoalbuminemic conditions could well be due to
a decrease in RCD related to an increase in LPC in the red cell
membrane, rather than to changes in plasma protein composition
such as hyperfibrinogenemia or hypertriglyceridemia. This does
not imply the latter do not contribute to atherosclerotic and
thrombotic risk via other mechanisms.
Thus, in the absence of albumin, circulating LPC is bound to
lipoproteins and red cells. As a consequence of the latter, RCD is
decreased and whole blood viscosity increased. These data
strongly suggest that alterations in red cell phospholipid compo-
sition are far more important than alterations in plasma fibrino-
gen or triglyceride levels in determining hyperviscosity in hy-
poalbuminemic conditions.
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